S. Louise Phanstiel - Jun 3, 2021 Form 4 Insider Report for MYRIAD GENETICS INC (MYGN)

Role: Director
Signature: By: Nathan A. Smith For: S. Louise Phanstiel
Stock symbol: MYGN
Transactions as of: Jun 3, 2021
Transactions value $: $0
Form type: 4
Date filed: 6/4/2021, 07:39 PM
Next filing: Jul 2, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MYGN	Common Stock	Award	$0	+12.8K	+19.27%	$0.00	79.5K	Jun 3, 2021	Direct	F1, F2
holding	MYGN	Common Stock						21K	Jun 3, 2021	The Phanstiel Trust	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Consists of restricted stock units granted pursuant to Myriad Genetics, Inc.'s 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of common stock and vests on the anniversary of the date of grant.
F2	The Reporting Person previously reported total beneficial ownership of 82,679 shares of common stock held directly and 5,000 shares of common stock held indirectly through The Phanstiel Trust. Except for the acquisition of 12,848 shares of common stock reported in this Form 4, the Reporting Person's total beneficial ownership of shares of common stock has not changed, but this Form 4 corrects the number of shares of common stock held directly by the Reporting Person and held indirectly by the Reporting Person through The Phanstiel Trust.

Content

Consists of restricted stock units granted pursuant to Myriad Genetics, Inc.'s 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of common stock and vests on the anniversary of the date of grant.

The Reporting Person previously reported total beneficial ownership of 82,679 shares of common stock held directly and 5,000 shares of common stock held indirectly through The Phanstiel Trust. Except for the acquisition of 12,848 shares of common stock reported in this Form 4, the Reporting Person's total beneficial ownership of shares of common stock has not changed, but this Form 4 corrects the number of shares of common stock held directly by the Reporting Person and held indirectly by the Reporting Person through The Phanstiel Trust.